| Axon ID |
Name |
Description |
From price |
|
1540
|
VX 680
|
Aurora inhibitor (non-specific) |
$66.00 |
|
1541
|
ZM 447439
|
Aurora B inhibitor |
$93.50 |
|
1580
|
AZD1152-HQPA
|
Aurora B inhibitor |
$77.00 |
|
1597
|
Aurora A inhibitor I
|
Aurora A inhibitor |
$137.50 |
|
1630
|
Aurora A inhibitor II
|
Aurora A inhibitor |
$137.50 |
|
1783
|
AMG 900
|
Aurora inhibitor (non-specific) |
$121.00 |
|
1836
|
CCT 137690
|
Aurora inhibitor (non-specific) |
$126.50 |
|
1961
|
MK 5108
|
Inhibitor of Aurora A kinase |
$121.00 |
|
2003
|
MLN8237
|
Second generation selective Aurora A inhibitor |
$99.00 |
|
2096
|
Hesperadin
|
Reversible and ATP-competitive inhibitor of Aurora B |
$104.50 |
|
2219
|
AT 9283
|
Multitargeted kinase inhibitor (Aurora A/B, JAK2/3, and BCR-Abl) |
$93.50 |
|
2570
|
FG-2216
|
Orally active HIF-PHD inhibitor that increases plasma EPO levels in vivo |
$88.00 |
|
2474
|
SPL-B
|
Inhibitor of TACC3 that inhibits nucleation of centrosome microtubules |
$137.50 |
|
2849
|
Apatinib
|
Inhibitor of VEGFR2 |
$132.00 |
|
2865
|
NVP-ACC789
|
Inhibitor of VEGFR2 |
$99.00 |
|
2906
|
SNS 314 mesylate
|
Potent and selective Aurora inhibitor (non-specific) |
$99.00 |
|
2837
|
BMS 605541
|
Potent, selective, orally active, and ATP-competitive VEGFR2 inhibitor |
$99.00 |
|
3407
|
LOXO-101 sulfate
|
First-in-class, potent, highly selective and ATP-competitive TRK inhibitor |
$88.00 |
|
3408
|
AKI603
|
Inhibitor of Aurora A kinase |
$159.50 |
|
3624
|
Toceranib phosphate
|
Multi-targeted receptor tyrosine kinase inhibitor |
$66.00 |
|
3758
|
LY-3295668
|
Orally available, potent and highly selective Aurora A kinase (AurA) inhibitor |
Inquire |
|
3789
|
YH-306
|
FAK inhibitor |
$99.00 |
|
3775
|
TrkB agonist prodrug R13
|
Prodrug of 7,8-Dihydroxyflavone; TrkB agonist |
$132.00 |
|
3901
|
LOXO-195
|
Trk inhibitor |
Inquire |
|
3920
|
GSK1070916
|
Potent, selective and ATP competitive inhibitor of Aurora B and C kinases |
$121.00 |
|
3946
|
Altiratinib
|
Balanced inhibitor for MET, TIE2 (TEK), and VEGFR2 (KDR) kinases |
Inquire |
|
3973
|
XL-228
|
Multitargeted protein kinase inhibitor (IGF1R, Aurora,FGFR, ABL,ALK and SRC) |
Inquire |
|
3975
|
MGCD265 dihydrochloride
|
Orally active, potent MET/SMO dual inhibitor |
$143.00 |
|
3998
|
MGCD516
|
Orally bioavailable receptor tyrosine kinase (RTK) inhibitor |
Inquire |
|
4038
|
CEP-37440 hydrochloride
|
Potent, selective and orally active inhibitor of ALK anf FAK |
Inquire |
|
4073
|
CYC-116
|
Aurora kinases A & B and VEGFR2 inhibitor |
Inquire |